{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:51:45Z","timestamp":1788918705835,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011789","name":"Department of Science and Technology of Jilin Province","doi-asserted-by":"publisher","award":["20210203068SF"],"award-info":[{"award-number":["20210203068SF"]}],"id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009991","name":"Department of Finance of Jilin Province","doi-asserted-by":"publisher","award":["JLSWSRCZX2021-056"],"award-info":[{"award-number":["JLSWSRCZX2021-056"]}],"id":[{"id":"10.13039\/501100009991","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jpba.2024.116099","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T12:13:39Z","timestamp":1709813619000},"page":"116099","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Simultaneous monitoring of seven antiepileptic drugs by dried blood spot and dried plasma spot sampling: method validation and clinical application of a LC\u2013MS\/MS-based technique"],"prefix":"10.1016","volume":"243","author":[{"given":"Haiwei","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruichen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2024.116099_bib1","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1111\/epi.17058","article-title":"C.A.A.E. Commission on Standardized Development of Epilepsy Centers, Epilepsy centers in China: current status and ways forward","volume":"62","author":"Lin","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.jpba.2024.116099_bib2","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/14656566.2023.2194488","article-title":"An update on potential pharmacotherapies for cognitive impairment in bipolar disorder","volume":"24","author":"Johnson","year":"2023","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.jpba.2024.116099_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s40272-020-00428-w","article-title":"Drug treatment of epilepsy neuropsychiatric comorbidities in children","volume":"23","author":"Holmes","year":"2021","journal-title":"Paediatr. Drugs"},{"key":"10.1016\/j.jpba.2024.116099_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.107657","article-title":"Adverse events related to antiepileptic drugs","volume":"115","author":"Dang","year":"2021","journal-title":"Epilepsy Behav.: EB"},{"key":"10.1016\/j.jpba.2024.116099_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0043-116492","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jpba.2024.116099_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2022.108904","article-title":"Effects of antiepileptic drugs polytherapy on pregnancy outcomes in women with epilepsy: an observation study in northwest China","volume":"135","author":"Shi","year":"2022","journal-title":"Epilepsy Behav.: EB"},{"key":"10.1016\/j.jpba.2024.116099_bib7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.seizure.2022.09.011","article-title":"Role of human leukocyte antigen in anti-epileptic drugs-induced Stevens-Johnson Syndrome\/toxic epidermal necrolysis: a meta-analysis","volume":"102","author":"Rashid","year":"2022","journal-title":"Seizure"},{"key":"10.1016\/j.jpba.2024.116099_bib8","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S1474-4422(20)30035-1","article-title":"30 years of second-generation antiseizure medications: impact and future perspectives","volume":"19","author":"Perucca","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jpba.2024.116099_bib9","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.5858\/arpa.2020-0562-CP","article-title":"Therapeutic drug monitoring of second- and third-generation antiepileptic drugs","volume":"145","author":"Krasowski","year":"2021","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.jpba.2024.116099_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.5393","article-title":"LC-MS\/MS quantification of levetiracetam, lamotrigine and 10-hydroxycarbazepine in TDM of epileptic patients","volume":"36","author":"Zhou","year":"2022","journal-title":"Biomed. Chromatogr.: BMC"},{"key":"10.1016\/j.jpba.2024.116099_bib11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.talanta.2013.02.010","article-title":"Fully validated method for rapid and simultaneous measurement of six antiepileptic drugs in serum and plasma using ultra-performance liquid chromatography-electrospray ionization tandem mass spectrometry","volume":"110","author":"Kuhn","year":"2013","journal-title":"Talanta"},{"key":"10.1016\/j.jpba.2024.116099_bib12","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1002\/jssc.202200025","article-title":"A sensitive LC-MS\/MS method for quantification of phenytoin and its major metabolite with application to in vivo investigations of intravenous and intranasal phenytoin delivery","volume":"45","author":"Prentice","year":"2022","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jpba.2024.116099_bib13","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jpba.2011.07.019","article-title":"Simple and accurate quantitative analysis of ten antiepileptic drugs in human plasma by liquid chromatography\/tandem mass spectrometry","volume":"56","author":"Kim","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116099_bib14","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1021\/ac303205m","article-title":"Dried blood spots: analysis and applications","volume":"85","author":"Demirev","year":"2013","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116099_bib15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jpba.2018.12.040","article-title":"LC-MS application for therapeutic drug monitoring in alternative matrices","volume":"166","author":"Avataneo","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116099_bib16","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/clinchem\/hvab058","article-title":"Measurement of immature reticulocytes in dried blood spots by mass spectrometry","volume":"67","author":"Cox","year":"2021","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jpba.2024.116099_bib17","doi-asserted-by":"crossref","first-page":"9395","DOI":"10.1021\/acs.analchem.8b02046","article-title":"Dried-blood-spot technique to monitor direct oral anticoagulants: clinical validation of a UPLC-MS\/MS-based assay","volume":"90","author":"Foerster","year":"2018","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116099_bib18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.chroma.2019.06.022","article-title":"Fully automated therapeutic drug monitoring of anti-epileptic drugs making use of dried blood spots","volume":"1601","author":"Velghe","year":"2019","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2024.116099_bib19","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1373\/clinchem.2016.263715","article-title":"Stable-Isotope Dilution HPLC-electrospray ionization tandem mass spectrometry method for quantifying hydroxyurea in dried blood samples","volume":"62","author":"Marahatta","year":"2016","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jpba.2024.116099_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2021.339231","article-title":"Development of an LC-MS\/MS method to simultaneously quantify therapeutic mAbs and estimate hematocrit values in dried blood spot samples","volume":"1189","author":"Chiu","year":"2022","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpba.2024.116099_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2023.340797","article-title":"Liquid chromatography-tandem mass spectrometry for therapeutic drug monitoring of immunosuppressants and creatinine from a single dried blood spot using the Capitainer(R) qDBS device","volume":"1242","author":"Deprez","year":"2023","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpba.2024.116099_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2021.338214","article-title":"Using matrix-induced ion suppression combined with LC-MS\/MS for quantification of trimethylamine-N-oxide, choline, carnitine and acetylcarnitine in dried blood spot samples","volume":"1149","author":"Lu","year":"2021","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpba.2024.116099_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2022.340650","article-title":"Development of the dried blood spot preparation protocol for comprehensive evaluation of the hematocrit effect","volume":"1239","author":"Cheng","year":"2023","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpba.2024.116099_bib24","doi-asserted-by":"crossref","first-page":"11501","DOI":"10.1021\/ac402735y","article-title":"Simple, miniaturized blood plasma extraction method","volume":"85","author":"Kim","year":"2013","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116099_bib25","doi-asserted-by":"crossref","first-page":"8787","DOI":"10.1021\/acs.analchem.6b02199","article-title":"Procedures for analysis of dried plasma using microsampling devices to detect sulfur mustard-albumin adducts for verification of poisoning","volume":"88","author":"John","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116099_bib26","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s12985-023-02225-6","article-title":"Development and evaluation of serological screening based on one dried plasma spot for HIV, syphilis, and HCV","volume":"20","author":"Ma","year":"2023","journal-title":"Virol. J."},{"key":"10.1016\/j.jpba.2024.116099_bib27","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1021\/ac102003t","article-title":"Use of dried plasma spots in the determination of pharmacokinetics in clinical studies: validation of a quantitative bioanalytical method","volume":"83","author":"Barfield","year":"2011","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116099_bib28","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1002\/jssc.201800579","article-title":"Application of a micro plasma collection card for the detection of homocysteine by liquid chromatography with tandem mass spectrometry","volume":"41","author":"Yuan","year":"2018","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jpba.2024.116099_bib29","doi-asserted-by":"crossref","first-page":"11229","DOI":"10.1021\/acs.analchem.6b03691","article-title":"A book-type dried plasma spot card for automated flow-through elution coupled with online SPE-LC-MS\/MS bioanalysis of opioids and stimulants in blood","volume":"88","author":"Ryona","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116099_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.5130","article-title":"Development and validation of an LC-MS\/MS method for relevant drugs in epilepsy patients using dried blood spots","volume":"35","author":"Moller","year":"2021","journal-title":"Biomed. Chromatogr.: BMC"},{"key":"10.1016\/j.jpba.2024.116099_bib31","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/FTD.0000000000000600","article-title":"LC-MS\/MS-based quantification of 9 antiepileptic drugs from a dried sample spot device","volume":"41","author":"D\u02bcUrso","year":"2019","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jpba.2024.116099_bib32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jpba.2015.02.023","article-title":"Quantitation of pregabalin in dried blood spots and dried plasma spots by validated LC\u2013MS\/MS methods","volume":"109","author":"Kosti\u0107","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116099_bib33","unstructured":"The European Medicines Agency. EMEA\/CHMP\/EWP\/192217\/2009: Guideline on bioanalytical method validation. The European Medicines Agency, (2011)."},{"key":"10.1016\/j.jpba.2024.116099_bib34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4155\/bio.14.298","article-title":"What is the right blood hematocrit preparation procedure for standards and quality control samples for dried blood spot analysis?","volume":"7","author":"Koster","year":"2015","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2024.116099_bib35","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/jssc.202100700","article-title":"Dried plasma spot-based liquid chromatography-tandem mass spectrometry for the quantification of methotrexate in human plasma and its application in therapeutic drug monitoring","volume":"45","author":"Cao","year":"2022","journal-title":"J. Sep. Sci."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524001390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524001390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T16:05:13Z","timestamp":1715270713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708524001390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":35,"alternative-id":["S0731708524001390"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116099","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simultaneous monitoring of seven antiepileptic drugs by dried blood spot and dried plasma spot sampling: method validation and clinical application of a LC\u2013MS\/MS-based technique","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116099","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116099"}}